Sensorimotor impairments in rats with cerebral infarction, induced by unilateral occlusion of the left middle cerebral artery: Strain differences and effects of the occlusion site

Brain Research

Volumn 735, Issue 2, 1996, Pages 271-284

  Van Der Staay, F Josef ^a   Augstein, Karl Heinz ^a   Horváth, Ervin ^a  

^a MEDA Manufacturing GmbH   (Germany)

Author keywords

Behavior; Behavioral examination; Focal cerebral ischemia; MCA; MCA O; Middle cerebral artery occlusion; Rat; Strain difference

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INFARCTION; CONTROLLED STUDY; HISTOLOGY; LOCOMOTION; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NONHUMAN; PRIORITY JOURNAL; RAT; STRAIN DIFFERENCE;

EID: 0030574105     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-8993(96)00607-5     Document Type: Article

References (44)

1. [1] Barone, F.C., Knudsen, D.J., Nelson, A.H., Feuerstein, G.Z. and Willette, R.N., Mouse strain differences in susceptibility to cerebral ischemia are related to cerebral vascular anatomy, J. Cereb. Blood Flow Metab., 13 (1993) 683-692.
2. [2] Barone, F.C., Price, W.J., White, R.F., Willette, R.N. and Feuerstein, G.Z., Genetic hypertension and increased susceptibility to cerebral ischemia, Neurosci. Biobehav. Rev., 16 (1992) 219-233.
3. [3] Barth, T.M. and Schallert, T., Somatosensorimotor function of the superior colliculus, somatosensory cortex, and lateral hypothalamus in the rat, Exp. Neurol., 95 (1987) 661-678.
4. [4] Bederson, J.B., Pitts, L.H., Tsuji, M., Nishimura, M.C., Davis, R.L. and Bartkowski, H., Rat middle cerebral artery occlusion: evaluation of the model and development of a neurological examination, Stroke, 17 (1986) 472-476.
5. 3 site ligand: a critical analysis of animal models of cerebral ischaemia and neurodegeneration, Brain Res., 522 (1990) 275-289.
6. [6] Breuer, Z. and Mayevsky, A., Brain vasculature and mitochondrial responses to ischemia in gerbils. II. Strain differences and statistical evaluation, Brain Res., 598 (1992) 251-256.
7. [7] Brito, G.N.O. and Brito, L.S.O., Septohippocampal system and the prelimbic sector of frontal cortex: a neuropsychological battery analysis in the rat, Behav. Brain Res., 36 (1990) 127-146.
8. [8] Coyle, P., Odenheimer, D.J. and Sing, C.F., Cerebral infarction after middle cerebral artery occlusion in progenies of spontaneously stroke-prone and normal rats, Stroke, 15(4) (1984) 711-716.
9. [9] Duverger, D., Lecoffre, C. and MacKenzie, E.T., Histological quantification of cerebral infarction following middle cerebral artery occlusion in various rat strains, J. Cereb. Blood Flow Metabol., 5 (Suppl. 1) (1985) S415-S416.
10. [10] Duverger, D. and MacKenzie, E.T., The quantification of cerebral infarction following focal ischemia in the rat: influence of strain, arterial pressure, blood glucose concentration, and age, J. Cereb. Blood Flow Metabol., 8 (1988) 449-461.
11. [11] Ellenbroek, B. and Cools, A.R., The paw test: an animal model for neuroleptic drugs which fulfils the criteria for pharmacological isomorphism, Life Sci., 42 (1988) 1205- 1213.
12. [12] Ellenbroek, B.A., Peeters, B.W., Honig, W.M. and Cools, A.R., The paw test: a behavioral paradigm for differentiating between classical and atypical neuroleptic drugs, Psychopharmacology, 93 (1987) 343-348.
13. [13] Garcia, J.H., Wagner, S., Liu, K.-F. and Hu, X.-j., Neurological deficit and extent of neuronal necrosis attributable to middle cerebral artery occlusion in rats, Stroke, 26 (1995) 627-635.
14. [14] Gotti, B., Benavides, J., MacKenzie, E.T. and Scatton, B., The pharmacotherapy of focal cortical ischemia in the mouse, Brain Res., 522 (1990) 290-307.
15. [15] Green, E.J., Dietrich, W.D., van Dijk, F., Busto, R., Markgraf, C.G., McCabe, P.M., Ginsberg, M.D. and Schneiderman, N., Protective effects of brain hypothermia on behavior and histopathology following global cerebral ischemia in rats, Brain Res., 580 (1992) 197-204.
16. [16] Hara, H., Kogure, K., Kato, H., Ozaki, A. and Sukamoto, T., Amelioration of brain damage after focal ischemia in the by a noval inhibitor of lipid peroxidalion, Eur. J. Pharmacol., 197 (1991) 75-82.
17. [17] Hunter, J.A., Green, R.A. and Cross, A.J., Animal models of acute ischaemic stroke: can they predict clinically successful neuroprotective drugs? Trends Pharmacol. Sci., 16 (1995) 123-128.
18. [18] Katsuta, K., Nakanishi, H., Shirakawa, K., Yoshida, K., Takagi, K. and Tamura, A., The neuroprotective effect of the novel noncompetitive NMDA antagonist, FR115427 in focal cerebral ischemia in rats, J. Cereb. Blood Flow Metab., 15 (1995) 345-348.
19. [19] Markgraf, C.G., Green, E.J., Hurwitz, B.E., Morikawa, E., Dietrich, W.D., McCabe, P.M., Ginsberg, M.D. and Schneiderman, N., Sensorimotor and cognitive consequences of middle cerebral artery occlusion in rats, Brain Res., 575 (1992) 238-246.
20. [20] McAuley, M.A., Patel, T.R., Galbraith, S. and McCulloch, J., Endothelin and its pathophysiological role in the cerebral circulation. In J. Krieglstein and H. Oberpichler-Schwenk (Eds.) Pharmacology of Cerebral Ischemia 1994, Wissenschaftliche Verlagsgesellschaft mbH, Stuttgart, 1994, pp. 511-524.
21. [21] Nordborg, C. and Johansson, B.B., Morphometric study on cerebral vessels in spontaneously hypertensive rats, Stroke, 11(3) (1980) 266-270.
22. [22] Obana, W.G., Pitts, L.H. and Nishimura, M.C., Effect of opiate antagonists on middle cerebral artery occlusion infarct in the rat, J. Neurosurg., 69 (1988) 98-103.
23. [23] Ohlsson, A.-L. and Johansson, B.B., Environment influences functional outcome of cerebral infarction in rats, Stroke, 26 (1995) 644-649.
24. [24] Oliff, H.S., Weber, E., Eilon, G. and Marek, P., The role of strain/vendor differences on the outcome of focal ischemia induced by intraluminal middle cerebral artery occlusion in the rat, Brain Res., 675 (1995) 20-26.
25. [25] Oliff, H.S., Weber, E., Miyazaki, B. and Marek, P., Infarct volume varies with rat strain and vendor in focal cerebral ischemia induced by transcranial middle cerebral artery occlusion, Brain Res., 699 (1995) 329-331.
26. [26] Park, C.K. and Hall, E.D., Dose-response analysis of the effect of 21-aminosteroid tirilazad mesylate (U-74006F) upon neurological outcome and ischemic brain damage in permanent focal cerebral ischemia, Brain Res., 645 (1994) 157-163.
27. [27] Paxinos, G. and Watson, C., The Rat Brain in Stereotaxic Coordinates, Academic Press, San Diego, 1986.
28. [28] Persson, L., Hårdemark, H., Bolander, H.G., Hillered, E. and Olsson, Y., Neurologic and neuropathologic outcome after middle cerebral artery occlusion in rats, Stroke, 20 (1989) 641-645.
29. [29] Russell, E.S., D.C. Gibson (Ed.) Development of the rodent as a mo del system in aging, DHEW publication no. (NIH) 72-121, Bethesda, 1972, pp. 33-53.
30. [30] Sauter, A. and Rudin, M., Strain-dependent drug effects in rat middle cerebral artery occlusion model of stroke, J. Pharmacol. Exp. Ther., 274 (1995) 1008-1013.
31. [31] Shigeno, T., McCulloch, J., Graham, D.I., Mendelow, A.D. and Teasdale, G.M., Pure cortical ischemia versus striatal ischemia. Circulatory, metabolic, and neuropathologic consequences, Surg. Neurol., 24 (1985) 47-51.
32. [32] Shiino, A., Experimental studies on pharmacologic protection of the brain against focal ischemia. 1. Focal brain ischemia model in rats, Arch. Jap. Chir., 58(5) (1989) 431-437.
33. [33] Shiraishi, K. and Simon, R.P., A model of proximal middle cerebral artery occlusion in rat, J. Neurosci. Methods, 30 (1989) 169-174.
34. [34] Tamura, A., Yamamoto, M., Shimizu, M., Kirino, T. and Sano, K., Behavioral change after focal cerebral ischemia in the rat, J. Cereb. Blood Flow Metabol., 5 (Suppl. 1) (1985) 379-380.
35. [35] Tominaga, T. and Ohnishi, S.T., Interrelationship of brain edema, motor deficits, and memory impairment in rats exposed to focal ischemia, Stroke, 20 (1989) 513-518.
36. [36] van der Staay, F.J., Augstein, K.-H. and Horváth, E., Sensorimotor impairments in Wistar-Kyoto rats with cerebral infarction, induced by unilateral occlusion of the middle cerebral artery: recovery of function, Brain Res., 715 (1996) 180-188.
37. [37] van der Staay, F.J., Kerbusch, S. and Raaijmakers, W., Genetic correlations in validating emotionality, Behav. Genet., 20 (1990) 51-62.
38. [38] Vrijmoed-de Vries, M.C., Tönissen, H. and Cools, A.R., The relationship between hindlimb disturbances, forelimb disturbances and catalepsy after increasing doses of muscimol injected into the striatal-pallidal complex, Psychopharmacology, 92 (1987) 73-77.
39. [39] Wahl, F., Allix, M., Plotkine, M. and Boulu, R.G., Neurological and behavioral outcomes of focal cerebral ischemia in rats, Stroke, 23 (1992) 267-272.
40. [40] Walsh, R.N. and Cummins, R.A., The open-field test: a critical review, Psychol. Bull., 83 (1976) 482-504.
41. [41] Welsh, F.A., Sakamoto, T., McKee, A.E. and Sims, R.E., Effect of lactacidosis on pyridine nucleotide stability during ischemia in mouse brain, J. Neurochem., 49 (1987) 846-851.
42. [42] Whishaw, I.Q., O'Connor, W.T. and Dunnett, S.B., Disruption of central cholingic systems in the rat by basal forebrain lesions or atropine: effects on feeding, sensorimotor behavior, locomotor activity and spatial navigation, Behav. Brain Res., 17 (1985) 103-115.
43. [43] Yamamoto, M., Tamura, A., Kirino, T., Shimizu, M. and Sano, K., Behavioral changes after focal cerebral ischemia by left middle cerebral artery occlusion in rats, Brain Res., 452 (1988) 323-328.
44. [44] Yamamoto, M., Tamura, A., Kirino, T., Shimizu-Sasamata, M. and Sano, K., Effects of thyrotropin-releasing hormone on behavioral disturbances in middle cerebral artery-occluded rats, Eur. J. Pharmacol., 197 (1991) 117-123.